Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/8814705

Download in:

View as

General Info

PMID
8814705